REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Inventage Lab Inc. (Seongnam) (South Korea)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Inventage Lab Inc. Profile Updated: July 04, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Inventage Lab Inc. is engaged in the manufacturing and sale of human medicines used for male pattern baldness, dementia, prostate cancer, and others. The company was incorporated in 2015 and is based in Seongnam, South Korea.

Headquarters
24, Dunchon-daero 388beon-gil Jungwon-gu Seongnam-si Gyeonggi
Seongnam; Gyeonggi;

Contact Details: Purchase the Inventage Lab Inc. (Seongnam) report to view the information.

Basic Information
Total Employees:
Purchase the Inventage Lab Inc. (Seongnam) report to view the information.
Outstanding Shares:
Purchase the Inventage Lab Inc. (Seongnam) report to view the information.
Registered Capital:
Purchase the Inventage Lab Inc. (Seongnam) report to view the information.
Incorporation Date:
May 14, 2015
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Senior Managing Director
Company Performance
Financial values in the chart are available after Inventage Lab Inc. (Seongnam) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
100.01%▲
Total operating revenue
100.01%▲
Operating profit (EBIT)
-14.06%▼
EBITDA
-9.9%▼
Net Profit (Loss) for the Period
-14.28%▼
Total assets
9.89%▲
Total equity
14.89%▲
Operating Profit Margin (ROS)
220.61%▲
Net Profit Margin
213.45%▲
Return on Equity (ROE)
0.19%▲
Debt to Equity Ratio
-4.73%▼
Quick Ratio
0.44%▲
Cash Ratio
1.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo